Teachers Advisors’s CytomX Therapeutics CTMX Stock Holding History

Teachers Advisors’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.5M	Buy	418,364 +228,540	+120%	+$3.38M	0.01%	1488
2018 Q4	$2.87M	Buy	189,824 +5,073	+3%	+$75.3K	﹤0.01%	1626
2018 Q3	$3.42M	Buy	184,751 +20,043	+12%	+$457K	﹤0.01%	1684
2018 Q2	$3.77M	Buy	164,708 +20,885	+15%	+$533K	﹤0.01%	1580
2018 Q1	$4.09M	Buy	143,823 +90,200	+168%	+$2.57M	0.01%	1423
2017 Q4	$1.13M	Buy	53,623 +1,412	+3%	+$29.3K	﹤0.01%	2179
2017 Q3	$949K	Hold	52,211	–	–	﹤0.01%	2262
2017 Q2	$809K	Buy	52,211 +17,250	+49%	+$260K	﹤0.01%	2351
2017 Q1	$604K	Hold	34,961	–	–	﹤0.01%	2441
2016 Q4	$384K	Buy	34,961 +2,209	+7%	+$26.8K	﹤0.01%	2673
2016 Q3	$514K	Hold	32,752	–	–	﹤0.01%	2454
2016 Q2	$335K	Buy	32,752 +25,089	+327%	+$286K	﹤0.01%	2637
2016 Q1	$99K	Hold	7,663	–	–	﹤0.01%	2941
2015 Q4	$160K	Buy	+7,663	New	+$121K	﹤0.01%	2929

Other funds holding CTMX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Teachers Advisors's CTMX Position: Q1 2019 in Review

Teachers Advisors increased its CytomX Therapeutics (CTMX) stake by 120% in Q1 2019, buying an estimated $3.38M and bringing the position to 418,364 shares worth $4.5M. The position accounts for 0.01% of the portfolio, ranked #1488.

Teachers Advisors first reported a position in CTMX in Q4 2015 and has held it in 14 quarters since. 113 funds tracked by Wall St. Rank hold CTMX as of Q1 2019.

Teachers Advisors held 418,364 shares of CytomX Therapeutics worth $4.5M as of Q1 2019.
Teachers Advisors bought 228,540 CytomX Therapeutics shares in Q1 2019, an estimated $3.38M.
CytomX Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1488 holding.
Teachers Advisors first reported a position in CytomX Therapeutics in Q4 2015 and has held it in 14 quarters since.
113 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.